These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 33342792)
1. Comparison of two hypofractionated radiotherapy schedules in locally advanced postmastectomy breast cancer patients. Choudhary S; Gupta N; Misra S; Munnee NN; Kumar A; Ranjan R; Dhar SS; Kumar D; Mourya A; Aggarwal LM J Cancer Res Ther; 2020; 16(6):1331-1335. PubMed ID: 33342792 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer. Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173 [TBL] [Abstract][Full Text] [Related]
3. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center? Yadav R; Lal P; Agarwal S; Misra S; Verma M; Das KJM; Senthil Kumar SK; Kumar A; Mishra SK; Agarwal A; Agarwal G; Mishra A; Chand G; Verma AK; Kumar S J Cancer Res Ther; 2020; 16(6):1314-1322. PubMed ID: 33342790 [TBL] [Abstract][Full Text] [Related]
4. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT. Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM; Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196 [TBL] [Abstract][Full Text] [Related]
5. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522 [TBL] [Abstract][Full Text] [Related]
6. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial. Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339 [TBL] [Abstract][Full Text] [Related]
7. Outcomes and toxicity following post-operative hypofractionated radiotherapy to the regional nodes and the breast or the chest wall in locally advanced breast cancer. Tramacere F; Arcangeli S; Colciago RR; Lucchini R; Pati F; Portaluri M Br J Radiol; 2022 Jul; 95(1135):20211299. PubMed ID: 35522785 [TBL] [Abstract][Full Text] [Related]
8. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer. Yadav BS; Sharma SC Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066 [TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study. De Matteis S; Facondo G; Valeriani M; Vullo G; De Sanctis V; Ascolese AM; Campanella B; Scalabrino G; Osti MF Clin Breast Cancer; 2022 Apr; 22(3):e332-e340. PubMed ID: 34670727 [TBL] [Abstract][Full Text] [Related]
10. Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018. Lam E; Chan S; Karam I; Lee J; Wong G; Zhang L; Vesprini D; Wronski M; Chin L; Razvi Y; McKenzie E; Rakovitch E; Chow E Clin Breast Cancer; 2020 Oct; 20(5):e612-e617. PubMed ID: 32321680 [TBL] [Abstract][Full Text] [Related]
11. Long-term treatment results of conventional and hypofractionation radiotherapy in postmastectomy cancer breast patients: A retrospective study from rural cancer center of Maharashtra, India. Jain VS; Bakshi N; Jain SM; Mandloi V; Malik Y; Kharde A J Cancer Res Ther; 2024 Jan; 20(1):396-403. PubMed ID: 38554352 [TBL] [Abstract][Full Text] [Related]
12. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer. Yadav BS; Sharma SC; Singh G; Dahiya D J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794 [TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions. Jiang H; Meng L; Zhang H; Dai X; Zhang Q; Ju Z; Yu W; Ma L BMC Cancer; 2021 Dec; 21(1):1284. PubMed ID: 34852776 [TBL] [Abstract][Full Text] [Related]
14. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity. Chitapanarux I; Klunklin P; Pinitpatcharalert A; Sripan P; Tharavichitkul E; Nobnop W; Onchan W; Chakrabandhu S; Jia-Mahasap B; Euathrongchit J; Wannasopha Y; Srisuwan T Radiat Oncol; 2019 Oct; 14(1):175. PubMed ID: 31610801 [TBL] [Abstract][Full Text] [Related]
15. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China. Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661 [TBL] [Abstract][Full Text] [Related]
16. Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial. Mutter RW; Giri S; Fruth BF; Remmes NB; Boughey JC; Harless CA; Ruddy KJ; McGee LA; Afzal A; Gao RW; Shumway DA; Vern-Gross TZ; Villarraga HR; Kenison SL; Kang Y; Wong WW; Stish BJ; Merrell KW; Yan ES; Park SS; Corbin KS; Vargas CE Lancet Oncol; 2023 Oct; 24(10):1083-1093. PubMed ID: 37696281 [TBL] [Abstract][Full Text] [Related]
17. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372 [TBL] [Abstract][Full Text] [Related]
18. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Murray Brunt A; Haviland JS; Wheatley DA; Sydenham MA; Alhasso A; Bloomfield DJ; Chan C; Churn M; Cleator S; Coles CE; Goodman A; Harnett A; Hopwood P; Kirby AM; Kirwan CC; Morris C; Nabi Z; Sawyer E; Somaiah N; Stones L; Syndikus I; Bliss JM; Yarnold JR; Lancet; 2020 May; 395(10237):1613-1626. PubMed ID: 32580883 [TBL] [Abstract][Full Text] [Related]
19. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control? Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802 [TBL] [Abstract][Full Text] [Related]
20. Survival Outcomes of Post-mastectomy Breast Cancer Patients Treated with Hypofractionated Radiation Treatment Compared to Conventional Fractionation -a Retrospective Cohort Study. Raveendran C; Meloot SS; Yadev I Gulf J Oncolog; 2023 May; 1(42):26-34. PubMed ID: 37283257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]